Posted AT 4:42 AM EDT on 22/03/06
Dying man denied free drug
As a retired carpenter who barely covers his monthly expenses, Raymond Bouchard was delighted to learn that he qualified to receive a free drug to treat the cancer that is killing him.
But Health Canada won't release Thalomid to him because a licensed alternative is available -- it just happens to come with a $35,000 price tag.
With Health Canada's recent decision to stop releasing Thalomid, which U.S.-based Celgene Corp.
The full text of this article has 1239 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
